Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Efficacy and safety of ClairYg®, a ready-to-use intravenous immunoglobulin, in adult patients with primary immune thrombocytopenia.

Slama B, Fain O, Maisonneuve H, Jourdan E, Viallard JF, Ouaja R, Alfa-Cissé O, Godeau B; Study Investigators..

Am J Blood Res. 2017 Jan 15;7(1):1-9.

2.

Role of Helicobacter pylori Eradication Therapy on Platelet Recovery in Chronic Immune Thrombocytopenic Purpura.

Sheema K, Ikramdin U, Arshi N, Farah N, Imran S.

Gastroenterol Res Pract. 2017;2017:9529752. doi: 10.1155/2017/9529752.

4.

Successful treatment of steroid-refractory immune thrombocytopenia with alemtuzumab.

Jung CW, Cho SH, Park S, Jang JH, Ji JH.

Blood Res. 2016 Dec;51(4):297-299. doi: 10.5045/br.2016.51.4.297. No abstract available.

5.

Efficacy and safety of thrombopoietin receptor agonists in patients with primary immune thrombocytopenia: A systematic review and meta-analysis.

Wang L, Gao Z, Chen XP, Zhang HY, Yang N, Wang FY, Guan LX, Gu ZY, Zhao SS, Luo L, Wei HP, Gao CJ.

Sci Rep. 2016 Dec 19;6:39003. doi: 10.1038/srep39003.

6.

Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: A retrospective study.

Liu Y, Chen S, Sun Y, Lin Q, Liao X, Zhang J, Luo J, Qian H, Duan L, Shi G.

Medicine (Baltimore). 2016 Dec;95(50):e5565.

7.

Long-term complications of splenectomy in adult immune thrombocytopenia.

Thai LH, Mahévas M, Roudot-Thoraval F, Limal N, Languille L, Dumas G, Khellaf M, Bierling P, Michel M, Godeau B.

Medicine (Baltimore). 2016 Nov;95(48):e5098.

8.

Low-level light treatment ameliorates immune thrombocytopenia.

Yang J, Zhang Q, Li P, Dong T, Wu MX.

Sci Rep. 2016 Nov 30;6:38238. doi: 10.1038/srep38238.

10.

The Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and Pathogenesis.

Consolini R, Legitimo A, Caparello MC.

Front Pediatr. 2016 Oct 19;4:102. Review.

11.

Prednison provokes serum and vasoactive substances in a mice model of immune thrombocytopenia.

Zhang L, Chen K, Li T, He H, Hou L, Wu X, Sun Y, Zheng L, Chen Z, Qin B, Chen X, Tian S.

Iran J Basic Med Sci. 2016 Sep;19(9):1010-1015.

12.
13.

Pulsed high-dose dexamethasone modulates Th1-/Th2-chemokine imbalance in immune thrombocytopenia.

Liu Z, Wang M, Zhou S, Ma J, Shi Y, Peng J, Hou M, Guo C.

J Transl Med. 2016 Oct 24;14(1):301.

14.

Intravenous Immunoglobulin (IVIg) Utilization in Immune Thrombocytopenia (ITP): A Multi-Center, Retrospective Review.

Hsia CC, Liu Y, Eckert K, Monga N, Elia-Pacitti J, Heddle NM.

Drugs Real World Outcomes. 2015 Mar;2(1):35-42.

15.

Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia.

Wei X, Gao J, Fang RH, Luk BT, Kroll AV, Dehaini D, Zhou J, Kim HW, Gao W, Lu W, Zhang L.

Biomaterials. 2016 Dec;111:116-123. doi: 10.1016/j.biomaterials.2016.10.003.

PMID:
27728811
16.

Rotavirus-associated immune thrombocytopenic purpura in children: A retrospective study.

Ai Q, Yin J, Chen S, Qiao L, Luo N.

Exp Ther Med. 2016 Oct;12(4):2187-2190.

17.

Laparoscopic splenectomy for primary immune thrombocytopenia: Current status and challenges.

Zheng D, Huang CS, Huang SB, Zheng CX.

World J Gastrointest Endosc. 2016 Sep 16;8(17):610-5. doi: 10.4253/wjge.v8.i17.610. Review.

18.

Successful Percutaneous Nephrolithotomy in Patients with Immune-Mediated Thrombocytopenia Treated with Romiplostim.

McCall AN, Ingimarsson JP, Morrisson GT, Hook CC, Krambeck AE.

J Endourol Case Rep. 2016 Apr 1;2(1):81-3. doi: 10.1089/cren.2016.0048.

19.

Immune thrombocytopenia and pregnancy.

Sankaran S, Robinson SE.

Obstet Med. 2011 Dec;4(4):140-6. doi: 10.1258/om.2011.110025. Review.

20.

Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia.

Perdomo J.

Immunotargets Ther. 2016 Feb 22;5:1-7. doi: 10.2147/ITT.S80648. Review.

Items per page

Supplemental Content

Support Center